Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
background. Through the 1990s laser treatment of leg veins has been a challenge. Newer, longer wavelength lasers with variable pulse width have shown promising results for both telangiectasia and reticular leg veins. Experience with these lasers for treatment of facial telangiectasia and periorbital reticular veins is scant. objective. To our knowledge this is the first prospective study to evaluate a variable pulse width, cryogen spray‐equipped 1064 nm Nd:YAG laser for the treatment of facial telangiectasia and larger periorbital reticular veins. methods. Seventeen volunteers, ages 32–67 years, skin types I–IV, with facial telangiectasia and reticular periorbital/temporal veins were treated once with the Nd:YAG laser at fluences of 125–150 J/cm2 with a 6 mm spot size and pulse widths of 25 msec for small vessels and 75–100 msec for reticular veins. Patients were examined 1 week and 1 month after the treatment. Pre‐ and posttreatment 35mm photographs were taken. Improvement was judged by two experienced physicians, both visually on patients and by comparison of pre‐ and posttreatment photographs. Results were graded as percent resolution, in five groups: 0%, 0–25%, 25–50%, 50–75%, and 75–100%. results. All 17 patients completed the study. Thirty‐two sites were treated (24 cheek, nose, and chin telangiectases, and 8 periorbital reticular veins). Greater than 75% improvement was observed in 97% of the treated sites. Greater than 50% improvement was observed in 100% of the treated sites. Notably, 100% of the facial reticular veins treated have essentially 100% resolution. Pain during treatment was variably perceived by patients, but occasionally sufficient for patients to express reservations about additional future treatment. Transient erythema and edema were common, but fine crusting was rare. Small areas of purpura were also quite rare. conclusion. The cryogen spray‐equipped 1064 nm Nd:YAG laser was remarkably effective and safe for skin type I–IV patients. It is an excellent tool for treatment of facial telangiectasia with minimal risk of purpura. For the first time we appear to have a simple, safe, and effective treatment for 1–2 mm periorbital reticular veins. The use of topical anesthesia may be needed for some patients.
Dermatologic Surgery – Wolters Kluwer Health
Published: Mar 1, 2002
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.